Correction: Analysis of mortality risk and influencing factors in female patients with young-onset type 2 diabetes - Scorecard - MDSpire

Correction: Analysis of mortality risk and influencing factors in female patients with young-onset type 2 diabetes

  • By

  • Ling Xiang

  • Mingmin Zhu

  • Zi Yan

  • Zhijin Geng

  • Yuankai Zhou

  • Zhongming Sun

  • Dandan Miao

  • Yong Zhang

  • Jinyi Zhou

  • Enchun Pan

  • Wen Hu

  • July 2, 2026

  • 0 min

Share

Clinical Scorecard: Correction: Reevaluation of Mortality Risk and Contributing Factors in Young-Onset Type 2 Diabetes Among Female Patients

At a Glance

CategoryDetail
ConditionYoung-Onset Type 2 Diabetes
Key MechanismsMortality risk and contributing factors
Target PopulationFemale patients with young-onset type 2 diabetes
Care SettingEndocrinology

Key Highlights

  • Correction of author affiliations
  • Updated affiliations for Jinyi Zhou
  • Clarification of hospital department names

Guideline-Based Recommendations

Diagnosis

  • Include relevant diagnostic criteria for young-onset type 2 diabetes.

Management

  • Outline management strategies specific to this population.

Monitoring & Follow-up

  • Specify monitoring recommendations for female patients.

Risks

  • Detail risks associated with young-onset type 2 diabetes.

Patient & Prescribing Data

Include specific treatment options or insights relevant to the patient population.

Clinical Best Practices

  • best_practices

Related Resources & Content

Original Source(s)

Correction: Analysis of mortality risk and influencing factors in female patients with young-onset type 2 diabetes

  • by Ling Xiang, Mingmin Zhu, Zi Yan, Zhijin Geng, Yuankai Zhou, Zhongming Sun, Dandan Miao, Yong Zhang, Jinyi Zhou, Enchun Pan, Wen Hu

  • July 2, 2026

Related Content

Outcomes of Metabolic and Bariatric Surgery Among Adolescents and Young Adults in Southern Louisiana

Multimodal machine learning for menopause status prediction using LLM-extracted ultrasound features

Deep learning-derived retinal biomarker associated with diabetes-related amputation in type 2 diabetes